Hazard
173 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 173 subpotency recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 15 (9%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all subpotency recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Pharmedium Services, LLC is recalling 500 syringes of fentanyl citrate due to confirmed subpotency. The product was distributed nationwide.
Pharmedium Services, LLC is recalling 350 syringes of Heparin Sodium Injection USP because confirmed subpotency and stability data do not support the expiry date.
Pharmedium Services, LLC is recalling specific lots of fentanyl citrate injection because confirmed subpotency and stability data do not support the expiry date.
Lyne Laboratories is recalling specific lots of Cyproheptadine Hydrochloride Syrup because the product was found to be subpotent. The recall affects 12,215 bottles distributed in New Jersey.
TMIG Inc is recalling Renovo Patch because it was marketed without FDA approval and three lots were found to be subpotent.
Boehringer Ingelheim Roxane Inc is recalling Acarbose 50 mg tablets because potency was below specification at a 9-month stability time point.
Mylan Institutional LLC is recalling specific lots of Nicardipine Hydrochloride Injection because the product failed potency and impurity specifications.
West-Ward Pharmaceutical Corp. is recalling 5,596 bottles of Ethambutol Hydrochloride Tablets, USP, 100 mg, due to an out-of-specification stability result.
American Health Packaging is recalling 2,005 cartons of Methylprednisolone 4 mg tablets because they failed to meet potency standards at a 6-month stability time point.
GlaxoSmithKline is recalling specific lots of Nicorette 2 mg lozenges because they failed quality specifications, including being overly thick, soft, and sub or superpotent.
Fresenius Kabi is recalling Heparin Sodium Injection vials because they may contain less active ingredient than labeled.
Actavis is recalling Gelnique (oxybutynin chloride) Gel 10% physician samples because drug potency was compromised during shipment.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl (levothyroxine sodium) tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Nexgen Pharma is recalling a specific lot of L-Arginine L-Ornithine Alpha Lipoic Acid capsules because the Alpha Lipoic Acid ingredient is subpotent.
Hill Dermaceuticals is recalling 8,736 bottles of Derma-Smoothe/FS topical oil because the product was found to be subpotent at the 12-month stability timepoint.
Physicians Total Care is recalling Levothyroxine Tablets, USP, 0.175 mg, due to subpotency and stability issues. The recall affects specific lots distributed in Ohio and Georgia.
Lloyd Inc. of Iowa is recalling 1.9 million Thyro-Tab 0.075 mg. tablets due to subpotency and stability issues.
Medtech Products Inc. is recalling Little Remedies For Tummys Stimulant Laxative Drops because the sennosides ingredient is subpotent.
Apotex Corp. is recalling specific lots of Leflunomide 10 mg tablets because they did not meet potency specifications.